As investors it's hard to let go sometimes. It's time to accept that rem-l as a treatment in any way shape or form to treat covid isn't going to happen. No EUA, It's done.
Yes we have some valuable data and with Novartis hopefully pursue a treatment for ards, a long way to go.
The CHF, CLBP & AGVHD treatments is where it's at.
What's everyone's expectations for the rest of the year? Any news upcoming other than OTAT? GL All
Rem-L needed Yesterday, page-2
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |